User Group Meetings
|
|
|
We are pleased to announce the co-sponsored User Group Meeting:
Usergroup Organizers: S. Zoffman, F. Hoffmann - La Roche Ltd., Basel; P. Schwarb, FMI, Basel; M. Simonen, D. Gabriel, Novartis, Basel;
More information about the program can be found here. |
|
|
|
|
We are pleased to announce the Lunch Tutorial of TTP Lab Tech. Time: 11.15 – 12.15
For more information please click here. |
|
|
|
|
SILA rapid integration™ Standardisation in Lab Automation! is pleased to announce its luncheon on Tuesday, October 13, 2009 |
 |
|
|
|
GPCR Interest Group
Full Day Meeting
Meeting Objectives Modulation of GPCR activities by antibodies in disease or drug discovery |
    |
|
Deep Sequencing Interest Group
Meeting Objectives Novel Technologies
More information about the program can be found here. |
        |
|
|
|
We are pleased to announce the Lunch Symposium of Invitrogen Accelerating early discovery candidates with advanced and modular cell Small molecule and biologics drug discovery for disease therapy has rapidly matured over the last decade. With that, the need for better biological models to identify, screen and validate these potential treatments has increased exponentially. To achieve better biology without sacrificing throughput, increasing biological complexity, or extending assay development time is a challenge that requires advances in cell based assay techniques and tools. Our toolbox is filled with off-the-shelf and enabling technologies that advance cell based assay development. With our technology toolbox and expertise we can flexibly partner with collaborators to provide, design, develop, and validate cell based assays to solve specific needs.
|
 |
Luncheon Cyntellect
Time: 11:15 – 12:15
Tuesday, 13 – Thursday, 15 October 2009
We are pleased to announce the Launch Seminars of GE Healthcare
The Future of Protein Chromatography – ÄKTA™ avant
Tuesday 13 October 11.00 – 12.00
Wednesday 14 October 14.30 – 15.30
Thursday 15 October 16.30 – 17.30
New Developments in High Content Analysis - IN Cell Analyzer 2000
Tuesday 13 October 09.30 – 10.30
Wednesday 14 October 16.30 – 17.30
Thursday 15 October 11.30 – 12.30
New Developments in High Content Analysis - IN Cell Analyzer 2000
High Content Analysis enables the high throughput study of cellular events and processes in true biological context. This tutorial discusses the latest hardware (IN Cell Analyzer 2000) and software developments from GE Healthcare, including image analysis and data management and how these features extend and enhance the quality of assay data with a series of application examples.
Dr. Christopher Norey, GE Healthcare Cardiff, United Kingdom
The Future of Protein Chromatography – ÄKTA™ avant, a new liquid chromatography system for fast and secure process development
GE Healthcare has been developing products and methodology for separation of biomolecules for more than 45 years. ÄKTAexplorer™ was launched in 1996, with features devised to help scientists overcome the difficulties of working with biological material. These features have become the blueprint for today’s ÄKTA™ design family. This proud lineage now sky rockets into the next generation with ÄKTA™ avant. Now we want to set the new industrial standard.
Using a newly developed chromatography instrument designed for fast and secure process development we demonstrated a rapid method development of a two step process for MAb purification from a challenging feed based on a clarified CHO cell supernatant. The method development included determination of elution-pH and dynamic binding capacity on MabSelect SuRe, and screening of loading conditions on Capto adhere using pH-elution experiment followed by a robustness- and verification study. The screening and robustness study was done using design of experiments (DoE).
Dr. Andreas Hochberger, GE Healthcare Saclay, France
We are pleased to announce the Lunch Symposium of Roche Diagnostics GmbH
The MagNA Pure 96 System - Automated Sample Preparation with REAL High-Throughput
The new MagNA Pure 96 System is designed for high throughput labs, processing up to 96 samples simultaneously, with run times of only 45-75 minutes, depending on the application. The system is based on the proven magnetic bead technology known from the well established MagNA Pure LC or MagNA Pure Compact systems.
C. Kappelsberger - Roche Diagnostics Penzberg
S. Kustermann - F. Hoffmann-La Roche Ltd Basel
Time: 13.15 – 14.15
The fast, flexible and reliable isolation of pure nucleic acids from various sample materials is crucial for sensitive molecular analysis by e.g. PCR, RT-PCR, sequencing, arrays etc. In addition, automation of this process is becoming increasingly important.
The new MagNA Pure 96 System is designed for high throughput labs, processing up to 96 samples simultaneously, with run times of only 45-75 minutes, depending on the application. The system is based on the proven magnetic bead technology known from the well established MagNA Pure LC or MagNA Pure Compact systems.
The new system is fully automated using ready-to-use prefilled reagents and specifically designed disposables for maximum user convenience. Viral nucleic acids, genomic DNA or total RNA from various sample materials can be isolated with high efficiency. Sample volumes of up to 1 ml can be processed.
The presentation will focus on the technical design and the available applications of this recently introduced system. Data will be presented to demonstrate the performance of the new system, using qPCR on the LightCycler® 480 System. In summary, the MagNA Pure 96 is capable of isolating nucleic acids with high recovery and purity, setting a new standard regarding speed, sample processing, error handling, process surveillance and data management.
We are pleased to announce the Lunch Symposium of Beckman Coulter
Automated Cell Culture and Cellular Analysis
Automated cell culturing for high-throughput applications
S. Junginger - Celisca - Center for Life Science Automation
Automated flow cytometry: from sample preparation to ‘HT-Flow Cytometry’
A. Hahn - Beckman Coulter Europe
Novel non-invasive cellular assays for the identification of anti-inflammatory compounds and inhibitors/promotors of cell migration on the Beckman Coulter Paradigm™ Detection Platform
H. Hundsberger - University of Applied Sciences
RNAi: automation from library handling to high-content analysis
C. Krüll - Beckman Coulter Europe
Pharmaceutical companies are investing in biotechnology to fill the pipeline for new drugs with biopharmaceuticals. Biotechnology uses biological systems to create proteins or nucleic acids that can be used as therapeutics.
Biopharmaceutical drugs have been developed for treatment of diseases such as cancer, anemia, and rheumatoid arthritis. Beckman Coulter has supplied automation systems into the Biopharma industry for several years. However research, production, and quality control of Biopharmaceuticals pose new challenges on process automation.
Time: 13.15 – 14.15
|
|
|
Drug Discovery Infrastructure Interest Group Time: 14.00 – 18.00
|
   |
Meeting Objectives
The objectives of this meeting is an open forum for both industry and scientists to discuss the potential and opportunities of open academic infrastructure (small and large scale facilities, specific knowledge) for drug discovery and development. During this meeting the following topics will be discussed:
Academic R&D services for drug development
Academic R&D services for biologicals and vaccines
Tracer development for improved therapy development
Screening platforms for chemical biology
We are pleased to announce the Lunch Symposium of Invitrogen
Simplified assays using fluorescent ion indicators for ion channels, transporters and GPCRs
David R. Piper - Invitrogen
Ion channels, transporters and GPCRs provide exciting opportunities for drug development aimed at diverse therapeutic areas including neurological, cardiovascular and pulmonary diseases, pain, and inflammation. To address these challenging targets in any desired cell background, researchers need an assortment of optimized assays. Innovative ion indicator detection tools offer solutions that can be readily configured to directly interrogate these targets and help reduce in-house assay development times.
Combined with flexible cell engineering platforms, immortalized, primary and stem cells, ion indicator tools provide a suite of solutions to directly examine the effects of small molecules on the activity of ion channels, transporters and GPCRs that are coupled to calcium, potassium and chloride flux or calcium release.
Time: 13.15 – 14.15
We are pleased to announce the Lunch Symposium of Bionas GmbH
Real-time cell analysis by measuring Bioenergetics and Cell Impedance
Time: 13.15 – 14.15
More information about the program can be found here.
We are pleased to announce the Lunch Symposium of LS Lab Services
PlateButler®: software the beating heart
PlateButler® is one of the star products in our successful range. It was developed in-house specifically to meet the increasing for compact, automated microplate systems. PlateButler® uses extremely flexible software, and can be set to match your requirements, turning your lab into a 24/7 workstation. We are a preferred supplier to the big names in life sciences, molecular biology and biotech, as well as leading universities an knowledge institutes.
PlateButler software introduction:
The scheduling software to automate your microplate application.
Ir. Ferry de Vugt.
Who should attend
Anyone looking for an introduction into the field of laboratory automation. This meeting will provide a general understanding of automation software with a very flexible set-up and scheduling tools, used for microplate applications.
Typical attendees include scientists, engineers, lab managers, and students.
How you’ll benefit from this meeting
- Learn writing assays as well as creating methods and interpretate scheduling steps. An interactive presentation.
- Learning the strategy and technical features of the software in relation to parallel assays.
- Understanding the issues, strategies and tools related to writing your own interfaces/clients.
Time: 13.15 – 14.15